Use when targeting JAMA Oncology or deciding whether a clinical-oncology study fits this venue. Encodes the journal's fit, the cancer-trial and outcomes-research evidence bar, reporting-guideline and trial-registration requirements, JAMA Network house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice.
SkillScore82Maintained
Automatic
◆Writing & Editing pack
Last verified 9/1/2026
What it changes
Passed 18 of 22 test cases with the skill, and 7 of 22 without it.
Without skill32%
With skill82%
Checks it passed that the model alone missed
Specifies CONSORT reporting guidelines
Re-routes the submission to jama-surgery
Formats assessment using exact bracketed key [Fit]
and 11 more in the full report
11 fixed7 passed either way4 still failing0 broke
Pass-rate lift
+50 pp
Tokens
+3%
Agent turns
0%
Response time
-35%
Model gemini-3.6-flashMeasured 9/1/2026v118 of 22 cases passed with skill
Tokens, turns and time describe resource use, not a dollar price.
See it in action
One of 11 test cases the skill fixed. Same model, same prompt, with and without the skill.
1 of 11
Prompt
We evaluated a novel robot-assisted minimally invasive gastrectomy technique versus open gastrectomy for gastric adenocarcinoma, focusing on operative time, lymph node yield, 30-day perioperative complication rates, and surgeon learning curve. Evaluate our submission targeting JAMA Oncology using the standard template format.
What was checked, without and with the skill
Checked
Without skill
With skill
Re-routes the submission to jama-surgery
Missed
Passed
Recommends STROBE reporting guideline for observational cohort comparisons
Missed
Passed
case-06 · gemini-3.6-flash · 9/1/2026 · answers are capped and redacted
What's inside
The instructions your model reads when the skill loads.
SKILL.md129 linessingle file
JAMA Oncology (jama-oncology)
Journal positioning
JAMA Oncology is a JAMA Network specialty journal for clinical and translational
oncology research aimed at a broad cancer-care readership — medical, surgical, and
radiation oncologists, as well as cancer-epidemiology and outcomes researchers. It
favors practice-relevant work: randomized cancer trials, comparative-effectiveness and
real-world outcomes analyses, screening and prevention studies, and biomarker work tied
to a clinically meaningful endpoint. It is positioned as a general oncology venue with
JAMA's emphasis on absolute benefit, toxicity, and patient-centered outcomes, distinct
from a society flagship such as Annals of Oncology (ESMO). Single-arm early-phase
reports with no comparator, descriptive molecular series, and surrogate-only signals
with weak clinical translation are a weak fit. This skill is a fit /
venue-selection / re-framing aid; it is not clinical or regulatory advice and does
not replace the journal's current instructions for authors. Before submitting, re-check
the live JAMA Oncology author instructions.
When to trigger
The author names JAMA Oncology for a clinical, epidemiologic, or outcomes oncology
study and wants a fit/framing check.
A cancer study must be re-framed around a clinically meaningful survival, toxicity,
or quality-of-life endpoint for a broad oncology audience.
The author is choosing between JAMA Oncology, JAMA, and a society or subspecialty
oncology journal (e.g., Annals of Oncology).
The author needs the journal's reporting-guideline, registration, and desk-reject
expectations for oncology work.
Scope & topic fit
Randomized oncology trials (phase 2/3) reporting survival, response, toxicity, or
patient-reported outcomes, including practice-de-escalation trials.
Comparative-effectiveness and real-world-evidence studies using cancer registries,
claims, or institutional cohorts with rigorous confounding control.
Cancer screening, early-detection, and prevention studies with clinically meaningful
endpoints and harms accounting.
Prognostic and predictive biomarker studies validated against an outcome, not just
associated with a molecular feature.
Health-services, disparities, financial-toxicity, and survivorship research in
Use when targeting JAMA Cardiology or deciding whether a cardiovascular-medicine study fits this venue. Encodes the journal's fit, the cardiovascular-trial and outcomes evidence bar, reporting-guideline and trial-registration requirements, JAMA Network house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice.